The startling findings raise the possibility that the medicines, originally developed to treat diabetes, could one day be ...
Users were quick to highlight one strikingly similar feature prolific among the A-listers gathered in Los Angeles - ...
Elon Musk wants to cut funding for scientific research, but the weight loss drugs he promoted also came from government funded basic science.
This will be a “pivotal year,” one expert says, for GLP-1 drugs, which are massively disrupting the benefits landscape.
People taking the weight-loss drug semaglutide could be at a slightly increased risk for a potentially blinding eye condition ...
The country's foremost expert on obesity has urged the Health Service Executive to make the 'King Kong' of weight loss drugs available free of charge.
Glucagon-like peptide 1 (GLP-1) drugs, such as Ozempic, are intended for type 2 diabetes patients and people with obesity, ...
Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...
Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Dems demand answers on workforce safety cutsThe top Democrats on the House Committee on Education ...
David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous value they offer.
Two Omaha women lost more than 300 lbs. combined with injections of a GLP-1 drug, which are used increasingly for weight loss ...
Polar Capital Global Healthcare, which is co-managed by James Douglas, currently trades at a 3pc discount to its assets.